RecruitingNot ApplicableNCT06323018

Effects of Remote Ischaemic Preconditioning in Cemented Hip Arthroplasty.

Effects of Remote Ischaemic Preconditioning in Cemented Total Hip Arthroplasty: Randomized Controlled Trial


Sponsor

University of Tartu

Enrollment

200 participants

Start Date

Mar 20, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Total joint arthroplasty is one of the best treatment options for end-stage osteoarthritis. Cemented hip arthroplasty is mainly indicated for elderly patients with poor bone quality and multiple comorbidities. Bone cement implantation syndrome is associated with cemented hip arthroplasty and it has been shown to increase cardiovascular and renal complication and brain damage postoperatively. The aim of this project is to elucidate whether remote-ischemic preconditioning (RIPC) has multi-organ protective effect in cemented hip arthroplasty patients.


Eligibility

Min Age: 65 YearsMax Age: 90 Years

Inclusion Criteria2

  • age >65 years
  • undergoing total hip cemented hip arthroplasty

Exclusion Criteria2

  • previously diagnosed peripheral artery disease on both upper limb
  • RIPC is contraindicated

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURERemote Ischemic Preconditioning

4 cycles of 5 min pressure (produces an ischemia episode in subject's upper limb) with AutoRIC device (Starfish Medical, Canada)

OTHERSHAM

4 cycles of 5min light pressure (no ischemia produced) with AutoRIC device (Starfish Medical, Canada) to imitate the RIPC procedure


Locations(1)

University of Tartu

Tartu, Tartu, Estonia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06323018


Related Trials